Penggao Dai
Overview
Explore the profile of Penggao Dai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xue S, Liu Y, Wang L, Zhang L, Chang B, Ding G, et al.
Front Genet
. 2024 Nov;
15:1347942.
PMID: 39568677
Introduction: Karyotyping and chromosome microarray analysis (CMA) are the two main prenatal diagnostic techniques currently used for genetic testing. We aimed to evaluate the value of chromosomal karyotyping and CMA...
2.
Liu Y, Liu S, Jing R, Li C, Guo Y, Cai Z, et al.
Sci Rep
. 2024 Sep;
14(1):20726.
PMID: 39251799
No abstract available.
3.
Wang X, Yan B, Li H, Yuan J, Guo J, Wang S, et al.
ACS Appl Mater Interfaces
. 2024 Jun;
16(24):30671-30684.
PMID: 38843203
Indoleamine 2,3-dioxygenase (IDO), highly expressed in hepatocellular carcinoma (HCC), plays a pivotal role in creating an immune-suppressive tumor microenvironment. Inhibiting IDO activity has emerged as a promising immunotherapeutic strategy; however,...
4.
Lu S, Li Z, Chen X, Chen F, Yao H, Sun X, et al.
Front Cell Infect Microbiol
. 2024 Apr;
14:1377225.
PMID: 38644962
Background: Bacterial vaginosis (BV) is a most common microbiological syndrome. The use of molecular methods, such as multiplex real-time PCR (mPCR) and next-generation sequencing, has revolutionized our understanding of microbial...
5.
Liu Y, Liu S, Jing R, Li C, Guo Y, Cai Z, et al.
Sci Rep
. 2024 Apr;
14(1):7666.
PMID: 38561384
Hepatocellular carcinoma (HCC) is a malignancy with poor prognosis. Abnormal expression of H3-H4 histone chaperones has been identified in many cancers and holds promise as a biomarker for diagnosis and...
6.
Xu K, Wang X, Hu S, Tang J, Liu S, Chen H, et al.
Heliyon
. 2024 Mar;
10(5):e27322.
PMID: 38463802
Sorafenib resistance is one of the main causes of poor prognosis in patients with advanced hepatocellular carcinoma (HCC). Long noncoding RNAs (lncRNAs) function as suppressors or oncogenic factors during tumor...
7.
Xue S, Wang L, Wei J, Liu Y, Ding G, Dai P
Front Genet
. 2023 Dec;
14:1319624.
PMID: 38155718
Spontaneous abortion is the most common complication of early pregnancy. In this study, we aim to investigate the clinical application value of genetic diagnosis using single nucleotide polymorphism (SNP) microarray...
8.
Yao H, Wang K, Lu S, Cao F, Dai P
Pharmacogenet Genomics
. 2023 Dec;
34(2):53-59.
PMID: 38050734
Objectives: HLA-B*13:01 was strongly associated with Dapsone Hypersensitivity Syndrome (DHS). This study aimed to develop and validate a rapid and economical method for HLA-B*13:01 genotyping. Methods: Two tubes multiplex real-time...
9.
Xi P, Liu S, Tang J, Wang X, Liu Y, Wang X, et al.
Biomed Pharmacother
. 2023 Dec;
170:115954.
PMID: 38039753
The potential of Ferrimagnetic vortex iron oxide nanoring-mediated mild magnetic hyperthermia (FVIO-MHT) in solid tumor therapy has been demonstrated. However, the impact of FVIO-MHT on the tumor microenvironment (TME) remains...
10.
Xue S, Zhu J, Zhang H, Han L, Yang R, Dai P, et al.
Clin Lab
. 2023 Sep;
69(9).
PMID: 37702680
Background: NeoSeq is a new method of gene sequencing for newborn screening. The goal is to explore the relationship between gene sequencing by NeoSeq combined with tandem mass spectrum (TMS)...